Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 06:00 am Sale |
2025-03-31 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 73,892 1.100% |
-21,153 (-22.26%) |
Filing History |
| 2025-01-24 09:52 am Purchase |
2025-01-23 | 13D | Cellectis S.A. CLLS |
ASTRAZENECA PLC | 44,000,000 44.000% |
28,000,000 (+175.00%) |
Filing History |
| 2024-10-28 06:00 am Purchase |
2024-10-23 | 13G | Monopar Therapeutics Inc. MNPR |
ASTRAZENECA PLC | 387,329 9.900% |
387,329 (New Position) |
Filing History |
| 2024-10-11 06:01 am Purchase |
2024-08-07 | 13G | Conduit Pharmaceuticals Inc. CDT |
ASTRAZENECA PLC | 95,045 9.900% |
95,045 (New Position) |
Filing History |
| 2024-02-12 10:13 am Unchanged |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
ASTRAZENECA PLC | 4,011,215 4.880% |
0 (Unchanged) |
Filing History |
| 2024-01-24 5:23 pm Sale |
2023-12-31 | 13G | AstraZeneca PLC AZN |
BLACKROCK INC BLK |
140,325,832 9.100% |
-8,700,570 (-5.84%) |
Filing |
| 2023-11-16 11:16 am Unchanged |
2023-11-14 | 13D | Cellectis S.A. CLLS |
ASTRAZENECA PLC | 16,000,000 22.400% |
0 (Unchanged) |
Filing History |
| 2023-11-09 5:07 pm Purchase |
2023-11-01 | 13D | Cellectis S.A. CLLS |
ASTRAZENECA PLC | 16,000,000 22.400% |
16,000,000 (New Position) |
Filing History |
| 2023-02-10 10:25 am Unchanged |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
ASTRAZENECA PLC | 884,956 3.400% |
0 (Unchanged) |
Filing History |
| 2023-02-10 10:22 am Unchanged |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
ASTRAZENECA PLC | 44,803 4.800% |
0 (Unchanged) |
Filing History |
| 2023-01-24 1:56 pm Sale |
2022-12-31 | 13G | AstraZeneca PLC AZN |
BLACKROCK INC BLK |
149,026,402 9.600% |
-8,364,904 (-5.31%) |
Filing |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | AstraZeneca PLC AZN |
BLACKROCK INC BLK |
157,391,306 10.200% |
18,458,884 (+13.29%) |
Filing |
| 2022-02-07 4:33 pm Purchase |
2021-12-31 | 13G | AstraZeneca PLC AZN |
BLACKROCK INC BLK |
138,932,422 9.000% |
23,755,621 (+20.63%) |
Filing |
| 2022-02-04 09:06 am Sale |
2021-12-31 | 13G | AstraZeneca PLC AZN |
WELLINGTON MANAGEMENT CO LLP | 65,542,362 4.230% |
-2,982,967 (-4.35%) |
Filing History |
| 2021-07-27 1:20 pm Purchase |
2021-07-20 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
ASTRAZENECA PLC | 884,956 7.300% |
884,956 (New Position) |
Filing History |
| 2021-04-07 5:37 pm Purchase |
2021-04-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
ASTRAZENECA PLC | 44,803 5.660% |
44,803 (New Position) |
Filing History |
| 2021-02-10 4:01 pm Purchase |
2020-05-11 | 13G | ADC Therapeutics SA ADCT |
ASTRAZENECA PLC | 4,011,215 5.230% |
4,011,215 (New Position) |
Filing History |
| 2021-02-10 4:01 pm Sale |
2020-12-31 | 13G | Moderna, Inc. MRNA |
ASTRAZENECA PLC | 0 0.000% |
-25,499,325 (Position Closed) |
Filing History |
| 2021-02-03 1:13 pm Sale |
2020-12-31 | 13G | AstraZeneca PLC AZN |
WELLINGTON MANAGEMENT CO LLP | 68,525,329 5.220% |
-8,978,560 (-11.58%) |
Filing History |
| 2021-01-28 6:11 pm Purchase |
2020-12-31 | 13G | AstraZeneca PLC AZN |
BLACKROCK INC BLK |
115,176,801 8.800% |
10,100,809 (+9.61%) |
Filing |